Clinical Trial Detail

NCT ID NCT02912559
Title Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

colon adenocarcinoma

Therapies

Atezolizumab + Fluorouracil + Leucovorin + Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: senior adult

Additional content available in CKB BOOST